Mitsubishi UFJ Trust & Banking’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.5M Sell
558,065
-38,626
-6% -$3.24M 0.11% 183
2026
Q1
$47.8M Sell
596,691
-85,212
-12% -$7.03M 0.12% 171
2025
Q4
$58.1M Sell
681,903
-125,516
-16% -$10.3M 0.14% 151
2025
Q3
$62.8M Sell
807,419
-25,276
-3% -$1.97M 0.14% 161
2025
Q2
$65.1M Sell
832,695
-223,792
-21% -$16.7M 0.15% 150
2025
Q1
$76.6M Sell
1,056,487
-55,349
-5% -$3.96M 0.2% 111
2024
Q4
$82.3M Sell
1,111,836
-437,338
-28% -$30.6M 0.19% 112
2024
Q3
$102M Buy
1,549,174
+20,756
+1% +$1.51M 0.23% 91
2024
Q2
$141M Sell
1,528,418
-32,284
-2% -$2.86M 0.34% 58
2024
Q1
$148M Sell
1,560,702
-75,100
-5% -$6.31M 0.34% 64
2023
Q4
$125M Buy
1,635,802
+42,294
+3% +$2.94M 0.29% 76
2023
Q3
$110M Buy
1,593,508
+172,707
+12% +$13.9M 0.28% 82
2023
Q2
$134M Buy
1,420,801
+213,448
+18% +$18.6M 0.31% 71
2023
Q1
$99.9M Buy
1,207,353
+294,877
+32% +$23.2M 0.24% 100
2022
Q4
$68.1M Buy
912,476
+24,485
+3% +$1.89M 0.18% 135
2022
Q3
$73.4M Sell
887,991
-56,817
-6% -$5.47M 0.21% 115
2022
Q2
$89.8M Buy
944,808
+31,590
+3% +$3.27M 0.23% 101
2022
Q1
$108M Sell
913,218
-176,814
-16% -$19.8M 0.25% 99
2021
Q4
$141M Sell
1,090,032
-42,041
-4% -$4.9M 0.29% 86
2021
Q3
$128M Sell
1,132,073
-315,347
-22% -$36M 0.28% 87
2021
Q2
$150M Sell
1,447,420
-59,415
-4% -$5.6M 0.32% 73
2021
Q1
$131M Sell
1,506,835
-115,808
-7% -$9.79M 0.29% 82
2020
Q4
$148M Buy
1,622,643
+17,442
+1% +$1.45M 0.3% 72
2020
Q3
$128M Buy
1,605,201
+114,533
+8% +$8.94M 0.29% 81
2020
Q2
$103M Buy
1,490,668
+479,446
+47% +$34.1M 0.25% 97
2020
Q1
$63.6M Buy
1,011,222
+447,993
+80% +$32.3M 0.19% 127
2019
Q4
$43.8M Sell
563,229
-6,054
-1% -$473K 0.1% 218
2019
Q3
$41.2M Sell
569,283
-8,286
-1% -$582K 0.11% 226
2019
Q2
$35.7M Buy
577,569
+62,190
+12% +$3.76M 0.12% 203
2019
Q1
$32.4M Sell
515,379
-333
-0.1% -$19K 0.12% 214
2018
Q4
$26.3M Sell
515,712
-8,565
-2% -$433K 0.11% 222
2018
Q3
$30.4M Sell
524,277
-773,895
-60% -$37.8M 0.11% 227
2018
Q2
$63M Sell
1,298,172
-63,252
-5% -$2.95M 0.11% 214
2018
Q1
$63.3M Buy
1,361,424
+9,780
+0.7% +$425K 0.11% 211
2017
Q4
$50.8M Buy
1,351,644
+69,135
+5% +$2.54M 0.09% 257
2017
Q3
$46.7M Sell
1,282,509
-7,764
-0.6% -$296K 0.09% 265
2017
Q2
$50.9M Sell
1,290,273
-7,608
-0.6% -$278K 0.1% 241
2017
Q1
$40.7M Buy
1,297,881
+729
+0.1% +$22.8K 0.08% 286
2016
Q4
$40.5M Sell
1,297,152
-28,020
-2% -$908K 0.09% 270
2016
Q3
$53.3M Buy
1,325,172
+7,335
+0.6% +$276K 0.11% 222
2016
Q2
$43.8M Buy
1,317,837
+45,990
+4% +$1.57M 0.1% 254
2016
Q1
$37.4M Buy
1,271,847
+7,779
+0.6% +$215K 0.08% 278
2015
Q4
$33.3M Sell
1,264,068
-1,842
-0.1% -$47.8K 0.08% 299
2015
Q3
$30M Buy
1,265,910
+15,408
+1% +$372K 0.07% 314
2015
Q2
$29.7M Buy
1,250,502
+33,792
+3% +$763K 0.07% 332
2015
Q1
$28.9M Buy
1,216,710
+46,266
+4% +$1.04M 0.07% 339
2014
Q4
$24.8M Buy
1,170,444
+17,442
+2% +$350K 0.06% 373
2014
Q3
$19.6M Sell
1,153,002
-89,790
-7% -$1.42M 0.05% 428
2014
Q2
$17.8M Buy
1,242,792
+1,026
+0.1% +$13.9K 0.04% 473
2014
Q1
$15.3M Sell
1,241,766
-18,522
-1% -$214K 0.04% 497
2013
Q4
$13.8M Sell
1,260,288
-32,586
-3% -$367K 0.03% 539
2013
Q3
$15M Buy
1,292,874
+12,612
+1% +$148K 0.04% 487
2013
Q2
$14.3M Buy
+1,280,262
New +$15.2M 0.04% 468

Other funds holding EW

Mitsubishi UFJ Trust & Banking's EW Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking reduced its Edwards Lifesciences (EW) stake by 6.5% in Q2 2026, selling an estimated $3.24M and leaving 558,065 shares worth $50.5M. The position accounts for 0.11% of the portfolio, ranked #183.

Mitsubishi UFJ Trust & Banking first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $150M in Q2 2021. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 558,065 shares of Edwards Lifesciences worth $50.5M as of Q2 2026.
  • Mitsubishi UFJ Trust & Banking sold 38,626 Edwards Lifesciences shares in Q2 2026, an estimated $3.24M.
  • Edwards Lifesciences made up 0.11% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #183 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
  • Mitsubishi UFJ Trust & Banking's Edwards Lifesciences position peaked at $150M in Q2 2021.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.